2Tomassoni D, Lanari A, Silvestrelli G, et al. Nimodipine and its use in- cerebrovascular disease: evidence from recent preclinical and con- trolledclinieal studies [ J ]. Clin Exp Hypertens,2008,30 ( 8 ) : 744.
4Tomassoni D, Lanari A, Silvestrelli G, et al. Nimodipine and its use in- cerebrovascular disease: evidence from recent preclinical and con- trolledclinical studies [ J ]. Clin Exp Hypertens, 2008,30 ( 8 ) :744.
7Tavernier B, Decamps F, Vega E, et al. Systemic treatments of thevaso- spasm Tavernier[ J ]. Ann Franesth Reanim, 2007,26 ( 11 ) : 980 - 984.
8Loch MR. Management of cerebral vasospasm [ J ]. Neurosurg Rev, 2006,29(3) :179 - 193.
9Raabe A, Beck J Berkefeld J, et al. Recommendations for them anage- ment of patients with aneurysmal subarachnoid hemorrhage [ J ]. Zen- tralbl Neurechir,2005,66 (2) :79 - 91.
10Skjoth R J, Schulz M, Kristensen SR, et al. Delayed neurological defi- cits detected by an ischemic pattern in the extracellulax cerebral me- tabolites in patients with aneurismal subarachnoid hemorrhage [ J ]. J Neurosurg,2004,100 ( 1 ) :8 - 15.
5WANG Hongcai,MA Yanbin.Experimental models of traumatic axo- nal injury [J].Joumal of Clinical Neuroscience,2009,17(2):157~162.
6Stone JR, Okonkwo DO, Dialo AO, et al. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol, 2004.190:59-69.
7kilinc D,Gallo G, Barbee KA, et al. Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol,2009,219: 553~561.
8Czeiter E, Buki A, Bukovics P, et al. Calpain inhibition reduces axolemmal leakage in traumatic axonal injury. Molecules, 2009, 14:5115-5123.
9Yang XF,Wang H ,Wen L, et al. atory responses: a vicious circle Hypotheses, 2011,77 : 60-62. From myelin debris to inflamm- in diffuse axonal injury. Med.
10Kadhim HJ, Duchateau J, Sebire G. Cytokines and brain injury: invited review. J Intensive Care Meal,2008,23: 236~249.
